Posts Tagged: Stem cell agency

News

Strapped stem cell agency winding down

A liquid nitrogen bank containing stem cells.(Photo: Alena Pavlovich, via Shutterstock)

The $3 billion California stem cell agency on Monday served up the bad news with only a smattering of sugar coating. No more applications for research funding are being accepted. The cash is running out, perhaps as early as the end of August.

News

Stem cell agency halts new grant applications

A stem cell researcher with microscope and digital tablet. (Photo: moreimages, via Shutterstock)

The $3 billion California stem cell agency, which is running out of cash, has served notice that it would stop accepting applications for more research awards beginning next month. The low key announcement on Thursday is another step towards the looming demise of the 14-year-old agency, created by voters in November 2004.

News

Trump action on fetal tissue research affects California

Cell research in a laboratory. (Photo: SBshot87, via Shutterstock)

President Trump has sharply cut back on federal funding for fetal tissue research in a move denounced as both politically motivated and destructive of the hopes of millions of Americans suffering from life-threatening diseases. 

Analysis

Stem cell funding’s ‘valley of death’

A scientist performs cell research within a sterile environment. (Photo: Tonhom1009, via Shutterstock)

ANALYSIS: The California stem cell agency this week is tooting a $150 million horn and heralding its efforts to assist stem cell businesses with development of therapies that could ease the travails of everything from cancer to blindness. It is all about a financial “valley of death” that can imperil biotech firms as they seek to turn research into an actual product that can be used by patients.

News

California’s gene therapy effort is nation’s first

The science of gene therapy and health care, a concept illustration. (Image: Kentoh, via Shutterstock)

California today became the first state in the nation to launch itself into the sizzling field of gene therapy, backed by tens of millions of dollars and with the hope of creating treatments that could permanently cure afflictions ranging from hemophilia to cancer.

News

Cash-strapped stem cell agency reaching out

An illustration of stem cells in mitosis. (Image via Shutterstock)

Stem cell researchers rarely have a chance to talk directly about their work to thousands of people at a time, including those in the farthest reaches of the globe. But Jeanne Loring at the Scripps Research Institute did it last week. The California stem cell agency did it last month with Stanford researcher Gary Steinberg.  And it could well be that the technique that they used will emerge as a critical tool in the effort to stave off the death of the $3 billion, stem cell program.

News

Stem cell agency plots against its own death

A pipette and recepticles used in stem cell research. (Photo: CI Photos)

California’s $3 billion stem cell research program later this month is expected to unveil detailed plans for extending its life beyond the middle of 2020 in hopes of avoiding a lingering death. The latest proposals, which are not yet public, are scheduled to be discussed Nov. 27.

News

Stem cell agency: $75 million for diabetes, brain cancer

Stem cell research in what's known as the "PCR strip." (Image: Science Photo, via Shutterstock)

The California stem cell agency yesterday handed out $75 million, doubling down on a couple of efforts to develop a stem cell therapy and a stem cell tool, plus funding an expansion of its Alpha Clinic network with two new, Northern California sites. The awards bring to $2.34 billion that the nearly 13-year-old agency has committed to stem cell research.

News

Stem cell agency eyes survival options

An illustration of stem cells used in research. (Photo: Billion Photos, via Shutterstock)

California’s $3 billion stem cell research agency, which is facing its financial demise in a few short years, has formed a team of its directors to tackle transition planning and examine possible alternatives, including ones that would extend its life. The first meeting of the group of directors is tentatively scheduled for Sept. 18. 

News

LAT: ‘Secret Life’ of former USC Med School dean, stem cell agency director

Carmen Puliafito (right), a member of the governing board of the California stem agency, and Robert Klein, then chairman of the agency. (Photo: USC, 2009)

The headline in the Los Angeles Times this morning said: “An overdose, a young companion, drug-fueled parties: The secret life of USC med school dean.” He resigned his $1.1 million position as dean in March 2016, declaring he wanted to pursue outside opportunities. He still serves, as a gubernatorial appointee, on the board of the California Institute for Regenerative Medicine (CIRM), as the stem cell agency is formally known.

Support for Capitol Weekly is Provided by: